RESEARCH
PUBLICATIONS
NEXTBIO COMMUNITY
A rare transmissible encephalopathy most prevalent between the ages of 50 and 70 years. Affected individuals may present with sleep disturbances, personality changes, ATAXIA; APHASIA, visual loss, weakness, muscle atrophy, MYOCLONUS, progressive dementia, and death within one year of disease onset. A familial form exhibiting autosomal dominant inheritance and a new variant CJD (potentially associated with ENCEPHALOPATHY, BOVINE SPONGIFORM) have been described. Pathological features include prominent cerebellar and cerebral cortical spongiform degeneration and the presence of PRIONS. (From N Engl J Med, 1998 Dec 31;339(27))
View Complete Description|
|
|
||
|---|---|---|---|
| PRNP |
100
|
||
| HLA-DQB1 |
81
|
Individual Studies |
|
|---|---|
|
|
Authors: J-P Brandel, D Galanaud, L Freeman, J L Laplanche, S Haik
Lancet 2010 Mar 13Authors: Stephen J Wroe, Suvankar Pal, Durrenajaf Siddique, Harpreet Hyare, Rebecca Macfarlane, Susan Joiner, Jacqueline M Linehan, Sebastian Brandner, Jonathan D F Wadsworth, Patricia Hewitt,…
Lancet 2006 Dec 9Thought leaders and organizations working on research involving creutzfeldt-jakob disease.
conditions: Creutzfeldt-Jakob Disease
interventions: Quinacrine
conditions: Alzheimer's Disease
interventions: Tryptophan
No NextBio users were found for “creutzfeldt-jakob disease”.
Complete
your user profile with your interests, if you want others to find you within the NextBio community.
No NextBio groups were found for “creutzfeldt-jakob disease”.
Be the first to
start
a group and share your interests with others within the NextBio community.